Medicare and the Shocking US Food and Drug Administration Approval of Aducanumab: Crisis or Opportunity? Crosson FJ, Covinsky K, Redberg RF. JAMA Intern Med 2021;181:1278-1280.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Crosson FJ, Covinsky K, Redberg RF. Medicare and the Shocking US Food and Drug Administration Approval of Aducanumab: Crisis or Opportunity? JAMA Intern Med 2021;181:1278-1280.
PMID: 34254992